logo
15:42 Mar 06

NGL Fine - Chem Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2404.90
+68.20 (+2.92%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NGL Fine - Chem Ltd. Financials

NGL Fine - Chem Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2404.90
+68.20 (+2.92%)
15:42 Mar 06
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

33/100
Mid Valuation

Technical

66/100
Technically Moderately Bullish

Strength

14

Weakness

2

Opportunity

0

Threats

0

7.47 %

ROE %

4.87 %

ROA %

56.82

EPS

457.16

BVPS

5.73 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
317.5 278.08 338.69 368.26 446.93
Operating Expenses +
249.66 243.76 285.42 334.39 390.16
Raw Material
169.67 116.41 170.81 182.41 231.17
Increase Decrease in Cost
-22.68 23.91 -12.13 -0.01 -14.7
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
34.85 36.87 45.12 55.55 62.79
Miscellaneous Expenses
67.82 66.57 81.62 96.44 110.9
Operating Profit
67.84 34.32 53.27 33.87 56.77
Other Income
10.68 5.53 14.13 8.63 12.04
Depreciation
10.37 11.29 11.64 12.45 17.85
Interest
1.56 1.2 1.34 2.33 4.42
Profit before tax and exceptio..
66.6 27.36 54.42 27.71 46.54
Exceptional Items
0 0 0 0 0
PBT
66.6 27.36 54.42 27.71 46.54
Provision for Taxation
16.7 6.87 13.1 6.59 11.44
Net Profit
49.9 20.5 41.32 21.12 35.1
NET Profit after MI
49.9 20.5 41.32 21.12 35.1
EPS
80.77 33.18 66.88 34.19 56.82
Operating Profit Margin (%)
21.37 12.34 15.73 9.2 12.7
Net Profit Margin (%)
15.72 7.37 12.2 5.74 7.85

NGL Fine - Chem Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 72.70 72.70 72.70 72.70 72.70 72.70
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 27.30 27.30 27.30 27.30 27.30 27.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: